Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial

Keyphrases

• Restless Legs Syndrome 100%
• Ferric Carboxymaltose 100%
• Randomized Trial 100%
• Non-anaemic Iron Deficiency 100%
• Placebo 57%
• Severity Scale 28%
• Serum Ferritin 28%
• Pathophysiology 14%
• Iron Status 14%
• Confidence Interval 14%
• Transferrin Saturation 14%
• Moderate to Severe 14%
• Tolerability 14%
• Non-endemic 14%
• Iron Deficient 14%
• L-ferritin 14%
• Intravenous Dose 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Ferric Carboxymaltose 100%
• Restless Legs Syndrome 100%
• Iron Deficiency 100%
• Placebo 57%
• Iron 42%
• Ferritin 28%
• Tolerability 14%
• Pathophysiology 14%
• Transferrin 14%